AAV9 gene therapy for Canavan disease
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AAV9 gene therapy for Canavan disease, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial) [Phase 1, Phase 2]